NEW YORK (GenomeWeb News) – Gene Express said today that it has signed three agreements with NeoGenomics Laboratories covering licensing, commercialization, and FDA validation of its gene expression and reverse transcription PCR technologies.

 

Under the terms of the agreements, NeoGenomics will license Gene Express’s Standardized Expression Measurement Center, or SEM Center, and Standardized Reverse Transcription Polymerase Chain Reaction, or StarRT-PCR, technology.